The pharmaceutical industry - To whom is it accountable? [1] (multiple letters)

New England Journal of Medicine

Volumn 343, Issue 19, 2000, Pages 1415-1417

  Holmer, A F ^a   Reif, M C ^a   Schwarting, J S ^a   Bohrer, R A ^a   Hayes, T A ^a   Rightor, N ^a   Summers, W K ^a   Driscoll, J ^a   Orient, J M ^a   Jacobs, C ^a   Mehta, D J ^a   Angell, M ^a  

^a Pharmaceut Res Manufacturers Amer   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

COST CONTROL; DRUG COST; DRUG INDUSTRY; GENE MAPPING; LETTER; MEDICAL GENETICS; PRIORITY JOURNAL; CHEMISTRY; ECONOMICS; NOTE; SOCIAL BEHAVIOR; UNITED STATES;

BUSINESS ETHICS; CLINICAL APPROACH/SOURCE; HEALTH CARE AND PUBLIC HEALTH;

ADVERTISING; CHEMISTRY, PHARMACEUTICAL; COST CONTROL; DRUG COSTS; DRUG INDUSTRY; ETHICS, BUSINESS; RESEARCH; SOCIAL RESPONSIBILITY; UNITED STATES;

EID: 0034627003     PISSN: 00284793     EISSN: None     Source Type: Journal    
DOI: 10.1056/NEJM200011093431913     Document Type: Letter

References (0)